These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
611 related items for PubMed ID: 11434684
1. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway. He R, Xiong S, He X, Liu F, Han J, Li J, He S. Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684 [Abstract] [Full Text] [Related]
2. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process]. He S, Xiong S, He R, He X, Liu F, Han J, Li J. Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967 [Abstract] [Full Text] [Related]
3. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Walsh PN. Thromb Haemost; 2001 Jul; 86(1):75-82. PubMed ID: 11487044 [Abstract] [Full Text] [Related]
4. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Nordfang O, Valentin S, Beck TC, Hedner U. Thromb Haemost; 1991 Oct 01; 66(4):464-7. PubMed ID: 1796397 [Abstract] [Full Text] [Related]
5. Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram. Takamiya O, Sakata M. Lab Hematol; 2008 Oct 01; 14(4):39-44. PubMed ID: 19095614 [Abstract] [Full Text] [Related]
6. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Wielders SJ, Béguin S, Hemker HC, Lindhout T. Arterioscler Thromb Vasc Biol; 2004 Jun 01; 24(6):1138-42. PubMed ID: 15072993 [Abstract] [Full Text] [Related]
10. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro. Minami H, Nogami K, Yada K, Ogiwara K, Furukawa S, Soeda T, Kitazawa T, Shima M. J Thromb Haemost; 2019 Jan 01; 17(1):126-137. PubMed ID: 30444568 [Abstract] [Full Text] [Related]
11. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA, Cox LM, Bouma BN. Blood Coagul Fibrinolysis; 2006 Jun 01; 17(4):251-7. PubMed ID: 16651866 [Abstract] [Full Text] [Related]
12. The role of factor XI in coagulation: a matter of revision. Minnema MC, Ten Cate H, Hack CE. Semin Thromb Hemost; 1999 Jun 01; 25(4):419-28. PubMed ID: 10548074 [Abstract] [Full Text] [Related]
17. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy. Bajaj SP, Joist JH. Semin Thromb Hemost; 1999 May 01; 25(4):407-18. PubMed ID: 10548073 [Abstract] [Full Text] [Related]
18. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Roberts HR. Thromb Haemost; 1998 Oct 01; 80(4):578-84. PubMed ID: 9798973 [Abstract] [Full Text] [Related]
19. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX. Visser M, van Oerle R, Ten Cate H, Laux V, Mackman N, Heitmeier S, Spronk HMH. Arterioscler Thromb Vasc Biol; 2020 Jan 01; 40(1):103-111. PubMed ID: 31766871 [Abstract] [Full Text] [Related]
20. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Nielsen VG, Cohen BM, Cohen E. Acta Anaesthesiol Scand; 2005 Feb 01; 49(2):222-31. PubMed ID: 15715625 [Abstract] [Full Text] [Related] Page: [Next] [New Search]